Trial Details

Not Recruiting
Basic Information
Clinical ID c3269
Identifier JPRN-UMIN000003230
Trial Title Alternative therapy using continuous intravenous administration of adrenomedullin for patients with inflammatory bowel disease - Continuous intravenous administration of adrenomedullin for patients with inflammatory bowel disease
Trial URL Visit Original Page
Study Information
Study Results

Yes

Conditions inflammatory bowel disease
Interventions Period up to 2 weeks (14 days) Drug dose continuous intravenous administration of adrenomedullin 1.5 pmol/kg/min for 8 hours per day (09:00 to 17:00)
Participant Information
Sponsor First Department of Internal Medicine, Faculty of Medicine, University of Miyazaki
City -
Country/Region Japan
Enrollment Criteria
Sex Requirement ALL
Age Requirement -
Study Design
Study Type Interventional
Phase PHASE2
Time Information
Start Date 2025-04-24
Primary Completion Date -
Completion Date 2012-12-01